Narrative review / 2021
Topical nicotinamide reduces the progression of skin aging and hyperpigmentation in clinical trials and is well tolerated by the skin.
This review summarizes the biological activities, metabolic pathways, and cosmeceutical properties of nicotinamide (niacinamide). Nicotinamide supplementation restores the cellular NAD+ pool, attenuates oxidative stress and inflammatory response, enhances the skin barrier, and inhibits skin pigmentation. Clinical trials indicate that topical treatment with nicotinamide, alone or combined with other active ingredients, reduces the progression of skin aging and hyperpigmentation while being well tolerated. Currently, convincing evidence that nicotinamide has specific molecular targets for controlling skin aging and pigmentation is lacking.
- Study type
- Review
- Who was studied
- Elderly individuals, clinical trial subjects, and patients with reduced NAD+
- What was measured
- Skin aging, skin hyperpigmentation, skin barrier, and tolerability
THE PAPER
Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation.
Boo YC. Antioxidants (Basel), 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.